| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDK17 SMG1 CDK18 CDC42BPA NEK6 CDK15 POLR2J3 SCYL3 POLR2J TENT5C SRPK1 SNRK CDKL1 MAP3K4 MET LRGUK AATK MTOR POLR2J2 CDK1 PRKAG2 TENT5D | 1.62e-06 | 938 | 148 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 2.57e-06 | 30 | 148 | 5 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 2.57e-06 | 30 | 148 | 5 | GO:0097472 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | CDK17 SMG1 CDK18 CDC42BPA NEK6 CDK15 SRPK1 SNRK CDKL1 MAP3K4 AATK MTOR CDK1 | 3.20e-06 | 363 | 148 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CDK17 SMG1 CDK18 CDC42BPA NEK6 CDK15 SRPK1 SNRK CDKL1 MAP3K4 AATK MTOR CDK1 PRKAG2 | 6.06e-06 | 446 | 148 | 14 | GO:0004674 |
| GeneOntologyMolecularFunction | protein kinase activity | CDK17 SMG1 CDK18 CDC42BPA NEK6 CDK15 SCYL3 SRPK1 SNRK CDKL1 MAP3K4 MET AATK MTOR CDK1 PRKAG2 | 1.01e-05 | 600 | 148 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | kinase activity | CDK17 SMG1 CDK18 CDC42BPA NEK6 CDK15 SCYL3 SRPK1 SNRK CDKL1 MAP3K4 MET LRGUK AATK MTOR CDK1 PRKAG2 | 5.30e-05 | 764 | 148 | 17 | GO:0016301 |
| GeneOntologyMolecularFunction | endoribonuclease activity, cleaving miRNA-paired mRNA | 5.46e-05 | 2 | 148 | 2 | GO:0090624 | |
| GeneOntologyMolecularFunction | RNA polymerase II activity | 6.30e-05 | 11 | 148 | 3 | GO:0001055 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDK17 SMG1 CDK18 CDC42BPA NEK6 CDK15 SCYL3 SRPK1 SNRK CDKL1 MAP3K4 MET AATK MTOR CDK1 PRKAG2 | 7.56e-05 | 709 | 148 | 16 | GO:0016773 |
| GeneOntologyBiologicalProcess | siRNA-mediated post-transcriptional gene silencing | 1.47e-06 | 4 | 149 | 3 | GO:0140766 | |
| GeneOntologyBiologicalProcess | siRNA-mediated gene silencing by mRNA destabilization | 1.47e-06 | 4 | 149 | 3 | GO:0090625 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 2.44e-05 | 266 | 149 | 10 | GO:0033044 | |
| GeneOntologyBiologicalProcess | regulation of attachment of spindle microtubules to kinetochore | 2.48e-05 | 24 | 149 | 4 | GO:0051988 | |
| GeneOntologyBiologicalProcess | RNA secondary structure unwinding | 3.01e-05 | 9 | 149 | 3 | GO:0010501 | |
| GeneOntologyBiologicalProcess | regulation of attachment of mitotic spindle microtubules to kinetochore | 4.27e-05 | 10 | 149 | 3 | GO:1902423 | |
| GeneOntologyBiologicalProcess | RISC complex assembly | 4.27e-05 | 10 | 149 | 3 | GO:0070922 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid segregation | 7.29e-05 | 60 | 149 | 5 | GO:0033047 | |
| GeneOntologyBiologicalProcess | microtubule-based process | DNHD1 DNAH3 CDC42BPA NEK6 ASH1L CLASP2 CUL7 MEI1 CDCA8 LYST ARMCX3 HNRNPU PRUNE1 MET LRGUK DST CDK1 CAMSAP1 GEN1 WDR72 | 7.72e-05 | 1058 | 149 | 20 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | CDK17 CDK18 ZWILCH TBRG4 BRIP1 SLF1 NEK6 CDK15 BIRC2 CUL7 CDCA8 CDKL1 HNRNPU IQGAP1 MET NABP2 EPC1 ZFYVE26 CDK1 CLSPN GEN1 MX2 | 1.01e-04 | 1256 | 149 | 22 | GO:0051726 |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 1.56e-04 | 111 | 149 | 6 | GO:0033045 | |
| GeneOntologyBiologicalProcess | regulation of metaphase plate congression | 1.58e-04 | 15 | 149 | 3 | GO:0090235 | |
| GeneOntologyBiologicalProcess | protein localization to kinetochore | 1.93e-04 | 16 | 149 | 3 | GO:0034501 | |
| GeneOntologyBiologicalProcess | protein localization to condensed chromosome | 1.93e-04 | 16 | 149 | 3 | GO:1903083 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CDC42BPA NEK6 CLASP2 CUL7 MEI1 CDCA8 HNRNPU PRUNE1 MET LRGUK DST CDK1 CAMSAP1 GEN1 WDR72 | 2.31e-04 | 720 | 149 | 15 | GO:0000226 |
| GeneOntologyBiologicalProcess | pre-miRNA processing | 2.33e-04 | 17 | 149 | 3 | GO:0031054 | |
| GeneOntologyBiologicalProcess | establishment of chromosome localization | 2.61e-04 | 122 | 149 | 6 | GO:0051303 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 2.71e-04 | 356 | 149 | 10 | GO:0098813 | |
| GeneOntologyBiologicalProcess | sperm DNA condensation | 2.78e-04 | 18 | 149 | 3 | GO:0035092 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 2.80e-04 | 292 | 149 | 9 | GO:0043488 | |
| GeneOntologyBiologicalProcess | nuclear division | ZWILCH BRIP1 CLASP2 CUL7 MEI1 CDCA8 HNRNPU MET BRDT CDK1 GEN1 TDRD12 | 3.52e-04 | 512 | 149 | 12 | GO:0000280 |
| GeneOntologyBiologicalProcess | chromosome localization | 3.67e-04 | 130 | 149 | 6 | GO:0050000 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | TBRG4 AGO2 TENT5C SRPK1 CWC22 HNRNPU AGO1 TOB1 AGO3 MTOR TENT5D | 3.84e-04 | 443 | 149 | 11 | GO:1903311 |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 3.91e-04 | 373 | 149 | 10 | GO:0006402 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 4.13e-04 | 308 | 149 | 9 | GO:0043487 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 4.22e-04 | 87 | 149 | 5 | GO:1902373 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 4.23e-04 | 309 | 149 | 9 | GO:0061013 | |
| GeneOntologyCellularComponent | RISC-loading complex | 4.11e-05 | 10 | 149 | 3 | GO:0070578 | |
| GeneOntologyCellularComponent | COPII vesicle coat | 1.86e-04 | 16 | 149 | 3 | GO:0030127 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 2.23e-04 | 287 | 149 | 9 | GO:0035770 | |
| GeneOntologyCellularComponent | RNA polymerase II, core complex | 2.24e-04 | 17 | 149 | 3 | GO:0005665 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 3.70e-04 | 20 | 149 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | AGO2 POLR2J3 POLR2J CUL7 HNRNPU MALT1 AGO1 TOB1 AGO3 PDRG1 MTOR EPC1 POLR2J2 OS9 KLHL12 PRKAG2 ARMC8 | 5.76e-04 | 972 | 149 | 17 | GO:0140535 |
| GeneOntologyCellularComponent | nuclear envelope | BRIP1 RGPD1 CC2D1B BCHE ITPR3 RIF1 DST MTOR MCM3AP EPC1 NXF1 MX2 | 6.92e-04 | 560 | 149 | 12 | GO:0005635 |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 7.08e-04 | 269 | 149 | 8 | GO:0036464 | |
| GeneOntologyCellularComponent | chromosomal region | 8.98e-04 | 421 | 149 | 10 | GO:0098687 | |
| Domain | ARM-type_fold | SMG1 SCYL3 CLASP2 CUL7 MEI1 CWC22 WDFY4 LYST ARMCX3 RYR3 FOCAD RIF1 CEBPZ MTOR PKP2 ARMC8 | 1.22e-08 | 339 | 148 | 16 | IPR016024 |
| Domain | LRR | LRRC63 LRRN1 TLR9 LRG1 TLR10 LRGUK LRRC53 SLIT3 LGR6 ANP32D NXF1 LRRC18 | 7.05e-08 | 201 | 148 | 12 | PS51450 |
| Domain | Kinase-like_dom | CDK17 SMG1 CDK18 CDC42BPA NEK6 CDK15 SCYL3 SRPK1 SNRK CDKL1 PRDM2 MAP3K4 MET AATK DST MTOR CDK1 | 1.44e-06 | 542 | 148 | 17 | IPR011009 |
| Domain | Leu-rich_rpt | LRRC63 LRRN1 TLR9 LRG1 TLR10 LRGUK LRRC53 SLIT3 LGR6 ANP32D NXF1 LRRC18 | 1.73e-06 | 271 | 148 | 12 | IPR001611 |
| Domain | RNA_POL_L_13KD | 1.94e-06 | 4 | 148 | 3 | PS01154 | |
| Domain | RNA_pol_Rpb11_13-16kDa_CS | 1.94e-06 | 4 | 148 | 3 | IPR008193 | |
| Domain | Argonaute_N | 1.94e-06 | 4 | 148 | 3 | IPR032474 | |
| Domain | Argonaute_Mid_dom | 1.94e-06 | 4 | 148 | 3 | IPR032473 | |
| Domain | ArgoL2 | 1.94e-06 | 4 | 148 | 3 | IPR032472 | |
| Domain | ArgoN | 1.94e-06 | 4 | 148 | 3 | PF16486 | |
| Domain | ArgoMid | 1.94e-06 | 4 | 148 | 3 | PF16487 | |
| Domain | ArgoL2 | 1.94e-06 | 4 | 148 | 3 | PF16488 | |
| Domain | DUF1785 | 4.82e-06 | 5 | 148 | 3 | SM01163 | |
| Domain | LRR_8 | 9.03e-06 | 171 | 148 | 9 | PF13855 | |
| Domain | ArgoL1 | 9.58e-06 | 6 | 148 | 3 | PF08699 | |
| Domain | RBP11-like_dimer | 9.58e-06 | 6 | 148 | 3 | IPR009025 | |
| Domain | ArgoL1 | 9.58e-06 | 6 | 148 | 3 | IPR014811 | |
| Domain | RNA_pol_L | 9.58e-06 | 6 | 148 | 3 | PF01193 | |
| Domain | - | LRRC63 LRRN1 TLR9 LRG1 TLR10 LRGUK LRRC53 SLIT3 LGR6 ANP32D NXF1 LRRC18 | 9.80e-06 | 321 | 148 | 12 | 3.80.10.10 |
| Domain | ARM-like | SMG1 SCYL3 CLASP2 CUL7 MEI1 WDFY4 ARMCX3 RIF1 MTOR PKP2 ARMC8 | 1.05e-05 | 270 | 148 | 11 | IPR011989 |
| Domain | LRR_TYP | 1.19e-05 | 177 | 148 | 9 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.19e-05 | 177 | 148 | 9 | IPR003591 | |
| Domain | L_dom-like | LRRC63 LRRN1 TLR9 LRG1 TLR10 LRGUK LRRC53 SLIT3 LGR6 ANP32D NXF1 LRRC18 | 1.22e-05 | 328 | 148 | 12 | IPR032675 |
| Domain | PIWI | 2.65e-05 | 8 | 148 | 3 | PS50822 | |
| Domain | Piwi | 2.65e-05 | 8 | 148 | 3 | SM00950 | |
| Domain | Piwi | 2.65e-05 | 8 | 148 | 3 | PF02171 | |
| Domain | Piwi | 2.65e-05 | 8 | 148 | 3 | IPR003165 | |
| Domain | PAZ | 3.96e-05 | 9 | 148 | 3 | PS50821 | |
| Domain | PAZ | 3.96e-05 | 9 | 148 | 3 | SM00949 | |
| Domain | PAZ | 3.96e-05 | 9 | 148 | 3 | PF02170 | |
| Domain | PAZ_dom | 3.96e-05 | 9 | 148 | 3 | IPR003100 | |
| Domain | Protein_kinase_ATP_BS | CDK17 CDK18 CDC42BPA NEK6 CDK15 SRPK1 SNRK CDKL1 MAP3K4 MET AATK CDK1 | 5.02e-05 | 379 | 148 | 12 | IPR017441 |
| Domain | LRR_1 | 6.37e-05 | 219 | 148 | 9 | PF00560 | |
| Domain | - | 7.07e-05 | 222 | 148 | 9 | 1.25.10.10 | |
| Domain | S_TKc | CDK17 CDK18 CDC42BPA NEK6 CDK15 SCYL3 SRPK1 SNRK CDKL1 MAP3K4 CDK1 | 1.39e-04 | 359 | 148 | 11 | SM00220 |
| Domain | Prot_kinase_dom | CDK17 CDK18 CDC42BPA NEK6 CDK15 SCYL3 SRPK1 SNRK CDKL1 MAP3K4 MET AATK CDK1 | 1.42e-04 | 489 | 148 | 13 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | CDK17 CDK18 CDC42BPA NEK6 CDK15 SCYL3 SRPK1 SNRK CDKL1 MAP3K4 MET AATK CDK1 | 1.54e-04 | 493 | 148 | 13 | PS50011 |
| Domain | RNA_pol_L_2 | 1.86e-04 | 3 | 148 | 2 | PF13656 | |
| Domain | Pkinase | CDK17 CDK18 CDC42BPA NEK6 CDK15 SCYL3 SRPK1 SNRK CDKL1 MAP3K4 CDK1 | 2.32e-04 | 381 | 148 | 11 | PF00069 |
| Domain | HEAT_REPEAT | 2.34e-04 | 70 | 148 | 5 | PS50077 | |
| Domain | - | DNHD1 TTF2 DNAH3 BRIP1 SAMD9 NOA1 CHD7 CMSS1 GFM2 HNRNPU LRGUK SBNO1 GFM1 TAP2 MX2 TDRD12 | 2.88e-04 | 746 | 148 | 16 | 3.40.50.300 |
| Domain | PROTEIN_KINASE_ATP | CDK17 CDK18 CDC42BPA NEK6 CDK15 SRPK1 SNRK CDKL1 MAP3K4 MET AATK CDK1 | 3.00e-04 | 459 | 148 | 12 | PS00107 |
| Domain | DUF1693 | 3.70e-04 | 4 | 148 | 2 | IPR012937 | |
| Domain | EFG_IV | 3.70e-04 | 4 | 148 | 2 | SM00889 | |
| Domain | EFG_IV | 3.70e-04 | 4 | 148 | 2 | PF03764 | |
| Domain | DUF1693 | 3.70e-04 | 4 | 148 | 2 | SM01153 | |
| Domain | Transl_elong_EFG/EF2_IV | 3.70e-04 | 4 | 148 | 2 | IPR005517 | |
| Domain | NTP_transf_7 | 3.70e-04 | 4 | 148 | 2 | PF07984 | |
| Domain | P-loop_NTPase | DNHD1 TTF2 DNAH3 BRIP1 SAMD9 NOA1 CHD7 CMSS1 GFM2 HNRNPU IQGAP1 LRGUK SBNO1 GFM1 TAP2 MX2 TDRD12 | 4.04e-04 | 848 | 148 | 17 | IPR027417 |
| Domain | Ser/Thr_kinase_AS | CDK17 CDK18 CDC42BPA NEK6 CDK15 SRPK1 SNRK CDKL1 MAP3K4 CDK1 | 5.67e-04 | 357 | 148 | 10 | IPR008271 |
| Domain | Autophagy-rel_C | 6.14e-04 | 5 | 148 | 2 | IPR015412 | |
| Domain | ATG_C | 6.14e-04 | 5 | 148 | 2 | PF09333 | |
| Domain | FATC | 6.14e-04 | 5 | 148 | 2 | PF02260 | |
| Domain | EFG_II | 6.14e-04 | 5 | 148 | 2 | PF14492 | |
| Domain | PROTEIN_KINASE_ST | CDK17 CDK18 CDC42BPA NEK6 CDK15 SRPK1 SNRK CDKL1 MAP3K4 CDK1 | 6.32e-04 | 362 | 148 | 10 | PS00108 |
| Domain | Sec23/24_helical_dom | 9.16e-04 | 6 | 148 | 2 | IPR006900 | |
| Domain | RIH_assoc-dom | 9.16e-04 | 6 | 148 | 2 | IPR013662 | |
| Domain | Sec23_24_beta_S | 9.16e-04 | 6 | 148 | 2 | IPR012990 | |
| Domain | zf-Sec23_Sec24 | 9.16e-04 | 6 | 148 | 2 | PF04810 | |
| Domain | Sec23_trunk | 9.16e-04 | 6 | 148 | 2 | PF04811 | |
| Domain | Sec23_helical | 9.16e-04 | 6 | 148 | 2 | PF04815 | |
| Domain | EFG_C | 9.16e-04 | 6 | 148 | 2 | PF00679 | |
| Domain | Ins145_P3_rec | 9.16e-04 | 6 | 148 | 2 | PF08709 | |
| Domain | RIH_assoc | 9.16e-04 | 6 | 148 | 2 | PF08454 | |
| Domain | EFG_III-V | 9.16e-04 | 6 | 148 | 2 | IPR009022 | |
| Domain | RIH_dom | 9.16e-04 | 6 | 148 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 9.16e-04 | 6 | 148 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 9.16e-04 | 6 | 148 | 2 | IPR015925 | |
| Domain | FAT | 9.16e-04 | 6 | 148 | 2 | PS51189 | |
| Domain | FATC | 9.16e-04 | 6 | 148 | 2 | PS51190 | |
| Domain | EFG_C | 9.16e-04 | 6 | 148 | 2 | SM00838 | |
| Domain | Sec23_BS | 9.16e-04 | 6 | 148 | 2 | PF08033 | |
| Domain | - | 9.16e-04 | 6 | 148 | 2 | 1.25.10.30 | |
| Domain | FATC_dom | 9.16e-04 | 6 | 148 | 2 | IPR003152 | |
| Domain | RYDR_ITPR | 9.16e-04 | 6 | 148 | 2 | PF01365 | |
| Domain | Sec23/24_trunk_dom | 9.16e-04 | 6 | 148 | 2 | IPR006896 | |
| Domain | Znf_Sec23_Sec24 | 9.16e-04 | 6 | 148 | 2 | IPR006895 | |
| Domain | PIK_FAT | 9.16e-04 | 6 | 148 | 2 | IPR014009 | |
| Domain | FATC | 9.16e-04 | 6 | 148 | 2 | SM01343 | |
| Domain | - | 1.28e-03 | 7 | 148 | 2 | 3.30.70.240 | |
| Domain | EFG_V | 1.28e-03 | 7 | 148 | 2 | IPR000640 | |
| Domain | Chorein_N | 1.69e-03 | 8 | 148 | 2 | PF12624 | |
| Domain | PH-BEACH_dom | 1.69e-03 | 8 | 148 | 2 | IPR023362 | |
| Domain | VPS13_N | 1.69e-03 | 8 | 148 | 2 | IPR026854 | |
| Domain | - | 1.69e-03 | 8 | 148 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.69e-03 | 8 | 148 | 2 | PS51783 | |
| Domain | Cadherin_2 | 1.76e-03 | 65 | 148 | 4 | PF08266 | |
| Domain | Cadherin_N | 1.76e-03 | 65 | 148 | 4 | IPR013164 | |
| Domain | BEACH | 2.16e-03 | 9 | 148 | 2 | PS50197 | |
| Domain | Beach | 2.16e-03 | 9 | 148 | 2 | PF02138 | |
| Domain | - | 2.16e-03 | 9 | 148 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.16e-03 | 9 | 148 | 2 | SM01026 | |
| Domain | G_TR_CS | 2.16e-03 | 9 | 148 | 2 | IPR031157 | |
| Domain | BEACH_dom | 2.16e-03 | 9 | 148 | 2 | IPR000409 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.65e-03 | 35 | 148 | 3 | IPR002464 | |
| Domain | MIR | 2.69e-03 | 10 | 148 | 2 | PF02815 | |
| Domain | MIR_motif | 2.69e-03 | 10 | 148 | 2 | IPR016093 | |
| Domain | MIR | 2.69e-03 | 10 | 148 | 2 | PS50919 | |
| Domain | MIR | 2.69e-03 | 10 | 148 | 2 | SM00472 | |
| Domain | DEAH_ATP_HELICASE | 3.36e-03 | 38 | 148 | 3 | PS00690 | |
| Pathway | BIOCARTA_DICER_PATHWAY | 3.97e-06 | 5 | 105 | 3 | M22079 | |
| Pathway | REACTOME_MICRORNA_MIRNA_BIOGENESIS | 7.90e-06 | 6 | 105 | 3 | MM14818 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 7.90e-06 | 6 | 105 | 3 | MM15083 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.38e-05 | 7 | 105 | 3 | M46421 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 2.19e-05 | 8 | 105 | 3 | MM15082 | |
| Pathway | REACTOME_MICRORNA_MIRNA_BIOGENESIS | 3.26e-05 | 25 | 105 | 4 | M712 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 3.26e-05 | 9 | 105 | 3 | M27340 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 3.26e-05 | 9 | 105 | 3 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 3.26e-05 | 9 | 105 | 3 | M46436 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 4.64e-05 | 10 | 105 | 3 | M48013 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 1.09e-04 | 13 | 105 | 3 | M46434 | |
| Pathway | PID_ARF6_PATHWAY | 1.27e-04 | 35 | 105 | 4 | M86 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 1.59e-04 | 37 | 105 | 4 | M29790 | |
| Pathway | WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING | 1.84e-04 | 71 | 105 | 5 | M39395 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 2.53e-04 | 17 | 105 | 3 | M27788 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 3.57e-04 | 19 | 105 | 3 | M48238 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 4.01e-04 | 129 | 105 | 6 | MM14894 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 4.03e-04 | 84 | 105 | 5 | M27495 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 4.05e-04 | 47 | 105 | 4 | M29777 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 4.76e-04 | 49 | 105 | 4 | MM14837 | |
| Pubmed | Turning catalytically inactive human Argonaute proteins into active slicer enzymes. | 8.02e-08 | 3 | 151 | 3 | 23665583 | |
| Pubmed | The roles of individual mammalian argonautes in RNA interference in vivo. | 8.02e-08 | 3 | 151 | 3 | 24992693 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 15284456 | ||
| Pubmed | 1.64e-07 | 12 | 151 | 4 | 19884882 | ||
| Pubmed | Molecular dissection of human Argonaute proteins by DNA shuffling. | 3.20e-07 | 4 | 151 | 3 | 23748378 | |
| Pubmed | [New genes on human chromosome 7: bioinformatic analysis of a gene cluster from the POLR2J family]. | 3.20e-07 | 4 | 151 | 3 | 15586814 | |
| Pubmed | Slicing-independent RISC activation requires the argonaute PAZ domain. | 3.20e-07 | 4 | 151 | 3 | 22795694 | |
| Pubmed | Importance of translation and nonnucleolytic ago proteins for on-target RNA interference. | 3.20e-07 | 4 | 151 | 3 | 18771919 | |
| Pubmed | A human RNA polymerase II subunit is encoded by a recently generated multigene family. | 3.20e-07 | 4 | 151 | 3 | 11747469 | |
| Pubmed | Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. | 3.20e-07 | 4 | 151 | 3 | 15260970 | |
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 19966796 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | SMG1 AGO2 CDC42BPA NEK6 BIRC2 SRPK1 CUL7 CDCA8 LYST MAP3K4 MET DST AGO1 AGO3 CDK1 PRKAG2 CLSPN | 5.00e-07 | 910 | 151 | 17 | 36736316 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TTF2 TBRG4 NOA1 VPS13C SEC24A ATG2B BIRC2 CUL7 CCDC51 TTC3 ARMCX3 GFM2 ITPR3 SPATS2L DST DHRS7 ITSN2 SEC24B PDCD11 MTX1 GFM1 GEN1 | 5.67e-07 | 1496 | 151 | 22 | 32877691 |
| Pubmed | 7.97e-07 | 5 | 151 | 3 | 19393748 | ||
| Pubmed | Quantitative functions of Argonaute proteins in mammalian development. | 7.97e-07 | 5 | 151 | 3 | 22474261 | |
| Pubmed | 7.97e-07 | 5 | 151 | 3 | 12414724 | ||
| Pubmed | 7.97e-07 | 5 | 151 | 3 | 19324964 | ||
| Pubmed | 7.97e-07 | 5 | 151 | 3 | 12526743 | ||
| Pubmed | Differential expression of components of the microRNA machinery during mouse organogenesis. | 7.97e-07 | 5 | 151 | 3 | 16036130 | |
| Pubmed | 7.97e-07 | 5 | 151 | 3 | 12036295 | ||
| Pubmed | 2.77e-06 | 7 | 151 | 3 | 28683311 | ||
| Pubmed | 2.77e-06 | 7 | 151 | 3 | 34907157 | ||
| Pubmed | 2.77e-06 | 7 | 151 | 3 | 19536157 | ||
| Pubmed | 2.77e-06 | 7 | 151 | 3 | 19383768 | ||
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 2.77e-06 | 7 | 151 | 3 | 19470757 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DNHD1 TBRG4 VPS13C CLASP2 THOC2 TTC3 CWC22 PRDM2 HNRNPU IQGAP1 RIF1 SBNO1 CEBPZ MTOR PDCD11 CDK1 GFM1 TALDO1 NXF1 ARMC8 | 3.93e-06 | 1425 | 151 | 20 | 30948266 |
| Pubmed | 4.42e-06 | 8 | 151 | 3 | 1639063 | ||
| Pubmed | Mili interacts with tudor domain-containing protein 1 in regulating spermatogenesis. | 4.42e-06 | 8 | 151 | 3 | 19345100 | |
| Pubmed | 4.42e-06 | 8 | 151 | 3 | 29021386 | ||
| Pubmed | SRPK1 CHD7 CUL7 THOC2 IQGAP1 ITPR3 RIF1 DST CEBPZ MTOR MCM3AP PDCD11 NXF1 | 6.01e-06 | 653 | 151 | 13 | 22586326 | |
| Pubmed | Identification of eight members of the Argonaute family in the human genome. | 6.61e-06 | 9 | 151 | 3 | 12906857 | |
| Pubmed | AGO2 CDC42BPA SRPK1 CLASP2 CHD7 CMSS1 THOC2 IQGAP1 RIF1 SPATS2L AGO3 CEBPZ MCM3AP PKP2 PDCD11 KLHL12 TALDO1 NXF1 MX2 | 8.37e-06 | 1371 | 151 | 19 | 36244648 | |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | CDK18 TTF2 CDC42BPA ESRRG SCYL3 ASH1L TENT5C LYST PRDM2 HNRNPU AGO1 MTOR LRRC53 LGR6 UBIAD1 CLSPN | 1.16e-05 | 1031 | 151 | 16 | 16710414 |
| Pubmed | HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies. | 1.29e-05 | 11 | 151 | 3 | 22915799 | |
| Pubmed | CDC42BPA VPS13C SCYL3 ATG2B LYST ARMCX3 ITPR3 SNX14 DST DHRS7 SEC24B | 1.38e-05 | 504 | 151 | 11 | 34432599 | |
| Pubmed | TTF2 CDC42BPA SEC24A ATG2B CC2D1B HNRNPU IQGAP1 PRUNE1 DST SEC24B PKP2 CDK1 CAMSAP1 | 1.42e-05 | 708 | 151 | 13 | 39231216 | |
| Pubmed | SMG1 AGO2 SLF1 CDC42BPA SEC24A RGPD1 CHD7 CUL7 PRDM2 RIF1 DST AGO1 AGO3 SEC24B EPC1 PDCD11 KDM1B NXF1 GABPA | 1.49e-05 | 1429 | 151 | 19 | 35140242 | |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 1.80e-05 | 186 | 151 | 7 | 33637726 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 26242502 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 15987790 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 27494364 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 22106001 | ||
| Pubmed | Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. | 1.87e-05 | 2 | 151 | 2 | 16936728 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 10534406 | ||
| Pubmed | Argonaute Family Protein Expression in Normal Tissue and Cancer Entities. | 1.87e-05 | 2 | 151 | 2 | 27518285 | |
| Pubmed | Resistance exercise with whey protein ingestion affects mTOR signaling pathway and myostatin in men. | 1.87e-05 | 2 | 151 | 2 | 19299575 | |
| Pubmed | Association of Polymorphic Variants in Argonaute Genes with Depression Risk in a Polish Population. | 1.87e-05 | 2 | 151 | 2 | 36142498 | |
| Pubmed | No association of TAP2 polymorphisms in Korean patients with schizophrenia. | 1.87e-05 | 2 | 151 | 2 | 15318034 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 11735030 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 38851619 | ||
| Pubmed | Polymorphisms and expression of genes encoding Argonautes 1 and 2 in autoimmune thyroid diseases. | 1.87e-05 | 2 | 151 | 2 | 29256262 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 21634124 | ||
| Pubmed | Argonaute proteins couple chromatin silencing to alternative splicing. | 1.87e-05 | 2 | 151 | 2 | 22961379 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 26885753 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 30520540 | ||
| Pubmed | Slicer Endonuclease Argonaute 2 Is a Negative Regulator of Hematopoietic Stem Cell Quiescence. | 1.87e-05 | 2 | 151 | 2 | 26850790 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 37219012 | ||
| Pubmed | Association study of AGO1 and AGO2 genes polymorphisms with recurrent pregnancy loss. | 1.87e-05 | 2 | 151 | 2 | 31666609 | |
| Pubmed | Alternative RISC assembly: binding and repression of microRNA-mRNA duplexes by human Ago proteins. | 1.87e-05 | 2 | 151 | 2 | 23019594 | |
| Pubmed | Enhanced susceptibility of Ago1/3 double-null mice to influenza A virus infection. | 1.87e-05 | 2 | 151 | 2 | 22318144 | |
| Pubmed | Human Argonaute2 and Argonaute3 are catalytically activated by different lengths of guide RNA. | 1.87e-05 | 2 | 151 | 2 | 33122430 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 31601460 | ||
| Pubmed | Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. | 1.87e-05 | 2 | 151 | 2 | 22858679 | |
| Pubmed | Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. | 1.87e-05 | 2 | 151 | 2 | 12230974 | |
| Pubmed | The Correct Localization of Borealin in Midbody during Cytokinesis Depends on IQGAP1. | 1.87e-05 | 2 | 151 | 2 | 32685508 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 19723326 | ||
| Pubmed | Evaluation of Argonaute protein as a predictive marker for human clear cell renal cell carcinoma. | 1.87e-05 | 2 | 151 | 2 | 23696926 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 21846468 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 12689944 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 31724726 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 2.05e-05 | 262 | 151 | 8 | 36880596 | |
| Pubmed | AGO2 CYTH3 CYTH2 RGPD1 CLASP2 CHD7 TTC3 HNRNPU IQGAP1 DST AGO1 AGO3 MTOR CAMSAP1 ARMC8 | 2.11e-05 | 963 | 151 | 15 | 28671696 | |
| Pubmed | SMG1 TBRG4 AGO2 CDC42BPA VPS13C SNRK CWC22 IQGAP1 DST SLIT3 PDCD11 | 2.15e-05 | 529 | 151 | 11 | 14621295 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | POLR2J3 CYTH3 POLR2J CHD7 CMSS1 MAP3K4 USP6 RIF1 AGO1 UGCG UBIAD1 | 2.43e-05 | 536 | 151 | 11 | 15840001 |
| Pubmed | POLR2J3 CYTH3 POLR2J CHD7 CMSS1 MAP3K4 USP6 RIF1 AGO1 UGCG UBIAD1 | 2.51e-05 | 538 | 151 | 11 | 10512203 | |
| Pubmed | 2.82e-05 | 274 | 151 | 8 | 34244482 | ||
| Pubmed | CDC42BPA NOA1 SRPK1 CLASP2 CHD7 CMSS1 IQGAP1 RIF1 SPATS2L DST CEBPZ ITSN2 SEC24B PDCD11 OS9 KDM1B NXF1 GABPA ARMC8 | 2.82e-05 | 1497 | 151 | 19 | 31527615 | |
| Pubmed | 3.51e-05 | 15 | 151 | 3 | 17400507 | ||
| Pubmed | VPS13C SEC24A SCYL3 CWC22 SPATS2L DHRS7 MCM3AP ITSN2 SEC24B PKP2 OS9 CDK1 UBIAD1 NXF1 GABPA | 3.52e-05 | 1007 | 151 | 15 | 34597346 | |
| Pubmed | 3.63e-05 | 284 | 151 | 8 | 29459677 | ||
| Pubmed | CDC42BPA VPS13C SEC24A SCYL3 CLASP2 ARMCX3 MET RIF1 DST SEC24B PKP2 CLSPN CAMSAP1 | 3.71e-05 | 777 | 151 | 13 | 35844135 | |
| Pubmed | Tooth morphogenesis and ameloblast differentiation are regulated by micro-RNAs. | 4.31e-05 | 16 | 151 | 3 | 20102707 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ZWILCH TBRG4 CYTH3 CYTH2 THOC2 TTC3 HNRNPU USP6 MALT1 SNX14 RIF1 CEBPZ POLR2J2 TAP2 | 5.47e-05 | 925 | 151 | 14 | 28986522 |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 27455076 | ||
| Pubmed | miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma. | 5.60e-05 | 3 | 151 | 2 | 24810336 | |
| Pubmed | Human PMS2 gene family: origin, molecular evolution, and biological implications. | 5.60e-05 | 3 | 151 | 2 | 16913423 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 32576681 | ||
| Pubmed | CDK1 substitutes for mTOR kinase to activate mitotic cap-dependent protein translation. | 5.60e-05 | 3 | 151 | 2 | 25883264 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 26926384 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 38479224 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 18042453 | ||
| Pubmed | EF-G2mt is an exclusive recycling factor in mammalian mitochondrial protein synthesis. | 5.60e-05 | 3 | 151 | 2 | 19716793 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 30551391 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 26473364 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 24086155 | ||
| Pubmed | Structural Basis of Diverse Homophilic Recognition by Clustered α- and β-Protocadherins. | 5.60e-05 | 3 | 151 | 2 | 27161523 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 24504412 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 35509083 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 28272965 | ||
| Pubmed | IQGAP1 regulates cell proliferation through a novel CDC42-mTOR pathway. | 5.60e-05 | 3 | 151 | 2 | 19454477 | |
| GeneFamily | Cyclin dependent kinases | 1.32e-07 | 26 | 86 | 5 | 496 | |
| GeneFamily | Argonaute/PIWI family | 5.72e-06 | 8 | 86 | 3 | 408 | |
| GeneFamily | RNA polymerase subunits | 3.47e-04 | 29 | 86 | 3 | 726 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 7.88e-04 | 9 | 86 | 2 | 1230 | |
| GeneFamily | CD molecules|Toll like receptors | 9.82e-04 | 10 | 86 | 2 | 948 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.12e-03 | 43 | 86 | 3 | 409 | |
| GeneFamily | Non-clustered protocadherins | 1.43e-03 | 12 | 86 | 2 | 21 | |
| GeneFamily | DNA helicases | 2.90e-03 | 17 | 86 | 2 | 1167 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | ZWILCH SAMD9 SRPK1 BCHE CMSS1 THOC2 TTC3 CWC22 GFM2 IQGAP1 RIF1 PDRG1 CEBPZ UGCG CDK1 CAMSAP1 TAP2 | 9.66e-07 | 721 | 151 | 17 | M10237 |
| Coexpression | LU_EZH2_TARGETS_DN | AGO2 SEC24A BIRC2 HNRNPU CENPQ ELL2 CCBE1 SEC24B ZFYVE26 KLHL12 TAP2 | 2.17e-05 | 400 | 151 | 11 | M2140 |
| Coexpression | GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_DN | 2.18e-05 | 200 | 151 | 8 | M7492 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | CDK17 SLC31A2 SEC24A CYTH2 CUL7 LYST ARMCX3 DST TOB1 AGO3 SBNO1 ITSN2 SEC24B UGCG NXF1 GABPA | 2.25e-05 | 822 | 151 | 16 | M6782 |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_UP | 5.17e-05 | 166 | 151 | 7 | M12595 | |
| Coexpression | GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP | 5.17e-05 | 166 | 151 | 7 | M9015 | |
| Coexpression | VILLANUEVA_LIVER_CANCER_KRT19_UP | 7.22e-05 | 175 | 151 | 7 | M336 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_UP | 1.09e-04 | 187 | 151 | 7 | MM1034 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CDK17 AGO2 CDC42BPA SEC24A CLASP2 THOC2 MAP3K4 USP6 MALT1 RIF1 ELL2 DST ITSN2 SEC24B UGCG | 1.33e-04 | 856 | 151 | 15 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CDK17 SMG1 SAMD9 SLF1 VPS13C ASH1L BIRC2 SNRK LYST PRDM2 HNRNPU IQGAP1 MALT1 RIF1 GVINP1 SBNO1 DHRS7 ITSN2 EPC1 TAP2 GABPA | 1.35e-04 | 1492 | 151 | 21 | M40023 |
| Coexpression | GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_UP | 1.51e-04 | 197 | 151 | 7 | M9730 | |
| Coexpression | GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN | 1.56e-04 | 198 | 151 | 7 | M8969 | |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | 1.61e-04 | 199 | 151 | 7 | M3417 | |
| Coexpression | GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP | 1.61e-04 | 199 | 151 | 7 | M7142 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_24H_BMDC_DN | 1.61e-04 | 199 | 151 | 7 | M3821 | |
| Coexpression | GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN | 1.61e-04 | 199 | 151 | 7 | M6837 | |
| Coexpression | GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP | 1.61e-04 | 199 | 151 | 7 | M9238 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | ZWILCH BRIP1 SLF1 IRAK1BP1 CHD7 TTC3 CDCA8 CENPQ RIF1 CDK1 CLSPN CAMSAP1 GEN1 | 1.63e-04 | 680 | 151 | 13 | MM456 |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 1.66e-04 | 200 | 151 | 7 | M9459 | |
| Coexpression | GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN | 1.66e-04 | 200 | 151 | 7 | M3276 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 1.66e-04 | 200 | 151 | 7 | M3580 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_UP | 1.66e-04 | 200 | 151 | 7 | M7516 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 1.66e-04 | 200 | 151 | 7 | M7532 | |
| Coexpression | GSE10325_BCELL_VS_LUPUS_BCELL_DN | 1.66e-04 | 200 | 151 | 7 | M3095 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CDC42BPA LRRN1 CYP2E1 VPS13C BIRC2 CHD7 NLGN1 CMSS1 HNRNPU RIF1 DST CEBPZ USP40 ZC3H12C CLSPN ERMARD | 1.27e-05 | 654 | 147 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | CDC42BPA LRRN1 CYP2E1 VPS13C ANO1 BIRC2 CHD7 NLGN1 CMSS1 CWC22 HNRNPU RIF1 AGO1 CEBPZ USP40 PCDH11X PKP2 ZC3H12C KDM1B CLSPN | 1.50e-05 | 983 | 147 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | ZWILCH TBRG4 BRIP1 AASDH CDCA8 CENPQ RIF1 ELL2 BRDT SBNO1 MTOR PKP2 PDCD11 KLHL12 CLSPN ERMARD TDRD12 | 4.71e-05 | 810 | 147 | 17 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | CYP27A1 TENT5C CHD7 TLR9 WDFY4 MET ELL2 DST ZC3H12C LRRC18 MX2 | 7.72e-05 | 384 | 147 | 11 | GSM605820_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CDK17 TTF2 VPS13C CHD7 TTC3 MAP3K4 HNRNPU CENPQ RIF1 CEBPZ ZC3H12C CLSPN GEN1 | 8.67e-05 | 532 | 147 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CDC42BPA LRRN1 CYP2E1 VPS13C BIRC2 CHD7 NLGN1 HNRNPU CEBPZ ZC3H12C | 9.89e-05 | 328 | 147 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | ZWILCH BRIP1 CDCA8 CENPQ RIF1 SBNO1 MTOR KLHL12 CLSPN ERMARD | 1.12e-04 | 333 | 147 | 10 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.17e-04 | 271 | 147 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.62e-08 | 130 | 152 | 8 | 615c233c7c2600c1c2bc5cf5b1c501fc474564ef | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.42e-07 | 172 | 152 | 8 | 1215f61f115b042f84721b64c2ed1f48081535f1 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-07 | 177 | 152 | 8 | c6812679aa6522d03bd29144e71c5fae6a92325e | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-07 | 177 | 152 | 8 | ff97398d2adb83063b7c53a264bfae86ea7ea304 | |
| ToppCell | LPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.10e-07 | 129 | 152 | 7 | 739b263296c28554967362060b154f7a95e1341d | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Serous|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.01e-07 | 197 | 152 | 8 | d3539607d5477f5dfd85f1fa99b74677c0fa8937 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Serous-Serous|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.01e-07 | 197 | 152 | 8 | 40bd7c314ff5254d87737822078e7b9eaf23edf3 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.49e-07 | 200 | 152 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-06 | 162 | 152 | 7 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-06 | 163 | 152 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-06 | 169 | 152 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-06 | 178 | 152 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-06 | 181 | 152 | 7 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-06 | 182 | 152 | 7 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.74e-06 | 194 | 152 | 7 | 5771a28a61f4d9b5479891f3224909ab003cb241 | |
| ToppCell | control-Lymphocytic-Prol._cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.74e-06 | 194 | 152 | 7 | 4c76508de3291c952386caffda2d559629ba5998 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, condition lineage and cell class | 5.07e-06 | 196 | 152 | 7 | e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.07e-06 | 196 | 152 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-cDC1|ICU-SEP / Disease, condition lineage and cell class | 5.25e-06 | 197 | 152 | 7 | e3174e90ea6136f1aa3a4a185b86458e35d51fd4 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.25e-06 | 197 | 152 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.25e-06 | 197 | 152 | 7 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.42e-06 | 198 | 152 | 7 | cd876fba12ff30b74aa507286cb1f3a867011a92 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.61e-06 | 199 | 152 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.61e-06 | 199 | 152 | 7 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 5.61e-06 | 199 | 152 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Transverse-(2)_B_cell-(24)_B_cell_cycling|Transverse / shred on region, Cell_type, and subtype | 5.79e-06 | 200 | 152 | 7 | e3f9736227151f23f0e331eec0a7a15ce464b517 | |
| ToppCell | Transverse-B_cell-B_cell_cycling|Transverse / Region, Cell class and subclass | 5.79e-06 | 200 | 152 | 7 | 0e270f8019d9f22068ca426d661937262a5cd331 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.79e-06 | 200 | 152 | 7 | ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.70e-06 | 140 | 152 | 6 | 5623a0a68403fc00166b7d13d13e184a718d9bdd | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.24e-05 | 149 | 152 | 6 | 2cd860b96ed4be4d26844085d464961c1418054a | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma|TCGA-Uterus / Sample_Type by Project: Shred V9 | 1.34e-05 | 151 | 152 | 6 | 2810bfa01bd3016aeba29735eb4a9284792e8aac | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-9|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.80e-05 | 159 | 152 | 6 | f376bf6cd0ed374211edac3c384f3a78f0caef2a | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.93e-05 | 161 | 152 | 6 | 0dd1401b4c990d49fccb702a9f9867590a58e203 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.93e-05 | 161 | 152 | 6 | b6a31c033edc74f23a20aab1f18e80cc83ffee4c | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.93e-05 | 161 | 152 | 6 | efb811dda4d73107983a5f68302bdcf4f408d5b4 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.93e-05 | 161 | 152 | 6 | 28d5dbd20c9f8e0069f172d552997a044790e1a7 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.07e-05 | 163 | 152 | 6 | a09449a502627aa369db600dba5bda93de7ce5c0 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-05 | 164 | 152 | 6 | 3caf4cdaa0164907893fea61e251fd8b5fa926e4 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.14e-05 | 164 | 152 | 6 | ed888b55d9c685096fd785878fcb264f4fee88d6 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.29e-05 | 166 | 152 | 6 | b1bebcbe17386cb102b11d551e62d46156ce0c68 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.37e-05 | 167 | 152 | 6 | e44743b20a7435c579d8e999ddc4ca119d6753f2 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.53e-05 | 169 | 152 | 6 | a1efc20e34a81ae32f8d278a5486811ade03ef24 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.80e-05 | 172 | 152 | 6 | 6fcc16f1067672967ecbcdfdc727649ae9891dd9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-05 | 173 | 152 | 6 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-05 | 173 | 152 | 6 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.98e-05 | 174 | 152 | 6 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC1|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.18e-05 | 176 | 152 | 6 | 87f90834c7278516beff7814b78f7c75732d9bf0 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 3.18e-05 | 176 | 152 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-05 | 176 | 152 | 6 | 4bba41ebf9dd187c8705a6997ed039878de62b4e | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 3.28e-05 | 177 | 152 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-05 | 178 | 152 | 6 | f815bc76f98aaea2d9058173b02b6f36e45283ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-05 | 178 | 152 | 6 | a0334764e865fea652c54b94bbc3b173f7cbc9fc | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.61e-05 | 180 | 152 | 6 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-05 | 180 | 152 | 6 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-05 | 180 | 152 | 6 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.72e-05 | 181 | 152 | 6 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.72e-05 | 181 | 152 | 6 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.72e-05 | 181 | 152 | 6 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.72e-05 | 181 | 152 | 6 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-05 | 181 | 152 | 6 | 5a4fe0eca7cbc9cbc8a2fdbe795a7c5f4052a659 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 182 | 152 | 6 | 3948422707d6d5e021bcd7158e2eb69143613f62 | |
| ToppCell | normal-na-Lymphocytic_B-B_mem-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.84e-05 | 182 | 152 | 6 | ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 182 | 152 | 6 | fe46819c153a81911864473badc794f243705f98 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 182 | 152 | 6 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 183 | 152 | 6 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.95e-05 | 183 | 152 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.95e-05 | 183 | 152 | 6 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 183 | 152 | 6 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-05 | 184 | 152 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-DC1|blood / Manually curated celltypes from each tissue | 4.08e-05 | 184 | 152 | 6 | 09fa465d1852b9b7e0405c27d4e5de276c9ba871 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-T_NK_proliferative|Bac-SEP / Disease, Lineage and Cell Type | 4.08e-05 | 184 | 152 | 6 | 848d05afd5a2ef61fb8a09c0f5fa2a56fd5c160b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-05 | 185 | 152 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-05 | 113 | 152 | 5 | 357bc20edc5bc14eab8262d52260ed1686e9dc54 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-05 | 113 | 152 | 5 | 91e73e3b93be242fef0f14eddd8085a1f1c730ef | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 4.33e-05 | 186 | 152 | 6 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 4.33e-05 | 186 | 152 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.33e-05 | 186 | 152 | 6 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.46e-05 | 187 | 152 | 6 | c8278525b3e1d3f3f4defcaf109cce22dd2e157a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-05 | 187 | 152 | 6 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.60e-05 | 188 | 152 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 4.60e-05 | 188 | 152 | 6 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.60e-05 | 188 | 152 | 6 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.73e-05 | 189 | 152 | 6 | 99b01893da9f9f7c9528afaffad178285211738b | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 189 | 152 | 6 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 189 | 152 | 6 | 96f10c63656e446b4bb712f012e91ae986f8c2d0 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.73e-05 | 189 | 152 | 6 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.87e-05 | 190 | 152 | 6 | f85cdd79eefd699ada7a91bf4997cc730a9b9846 | |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | 5.02e-05 | 191 | 152 | 6 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.02e-05 | 191 | 152 | 6 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 5.02e-05 | 191 | 152 | 6 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | Control-Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.02e-05 | 191 | 152 | 6 | 3df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.02e-05 | 191 | 152 | 6 | b978afe76754cc56e1672abca27be289bb56375b | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 192 | 152 | 6 | 96f23d6e8604d1cb24910d3118d8171b57c93e14 | |
| ToppCell | COVID-19_Severe-Plasmablast|World / disease group, cell group and cell class | 5.17e-05 | 192 | 152 | 6 | a333053fe2bd206c32790916bfc5fce904ab7f57 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.17e-05 | 192 | 152 | 6 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.32e-05 | 193 | 152 | 6 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | 368C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.32e-05 | 193 | 152 | 6 | 5f5904cec8b2967154ef2eab3c48f51df53aca4a | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 5.32e-05 | 193 | 152 | 6 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.47e-05 | 194 | 152 | 6 | 91205b22650e7ecdb72bb59348ce2530b76c532c | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.47e-05 | 194 | 152 | 6 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| Disease | neutrophil gelatinase-associated lipocalin measurement | 7.17e-05 | 3 | 145 | 2 | EFO_0021964 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 9.43e-05 | 148 | 145 | 6 | C0279702 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.09e-04 | 152 | 145 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 1.43e-04 | 4 | 145 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 3.12e-04 | 27 | 145 | 3 | DOID:0050453 (implicated_via_orthology) | |
| Disease | anti-drug antibody measurement | 3.55e-04 | 6 | 145 | 2 | EFO_0010559 | |
| Disease | glomerular filtration rate, creatine measurement | 3.55e-04 | 6 | 145 | 2 | EFO_0005208, EFO_0010472 | |
| Disease | mean corpuscular hemoglobin concentration | BRIP1 SAMD9 AGO2 SLC31A2 TENT5C SRPK1 CDKL1 FOCAD RIF1 ELL2 BRDT CCBE1 UGCG PRKAG2 CLSPN | 3.69e-04 | 1105 | 145 | 15 | EFO_0004528 |
| Disease | Epileptic encephalopathy | 4.28e-04 | 30 | 145 | 3 | C0543888 | |
| Disease | gout | 4.31e-04 | 196 | 145 | 6 | EFO_0004274 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 4.36e-04 | 128 | 145 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 4.36e-04 | 128 | 145 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 4.36e-04 | 128 | 145 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 4.36e-04 | 128 | 145 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 4.36e-04 | 128 | 145 | 5 | C0007134 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 4.72e-04 | 31 | 145 | 3 | C1335167 | |
| Disease | glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement | 6.59e-04 | 8 | 145 | 2 | EFO_0800533 | |
| Disease | photoreceptor cell layer thickness measurement | 8.42e-04 | 148 | 145 | 5 | EFO_0803370 | |
| Disease | Sjogren's Syndrome | 1.81e-03 | 13 | 145 | 2 | C1527336 | |
| Disease | Sicca Syndrome | 1.81e-03 | 13 | 145 | 2 | C0086981 | |
| Disease | blood urea nitrogen measurement | 1.83e-03 | 452 | 145 | 8 | EFO_0004741 | |
| Disease | Autistic Disorder | 1.89e-03 | 261 | 145 | 6 | C0004352 | |
| Disease | triacylglycerol 46:0 measurement | 2.41e-03 | 15 | 145 | 2 | EFO_0010400 | |
| Disease | Malignant neoplasm of breast | BRIP1 NOA1 BIRC2 BCHE TTC3 RIF1 SBNO1 MTOR ITSN2 ZFYVE26 LGR6 CLSPN GEN1 | 2.53e-03 | 1074 | 145 | 13 | C0006142 |
| Disease | serum urea measurement | 2.83e-03 | 195 | 145 | 5 | EFO_0009795 | |
| Disease | proliferative diabetic retinopathy | 3.40e-03 | 61 | 145 | 3 | EFO_0009322 | |
| Disease | Myeloid Leukemia | 3.48e-03 | 18 | 145 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 3.48e-03 | 18 | 145 | 2 | C0023466 | |
| Disease | Liver carcinoma | 3.69e-03 | 507 | 145 | 8 | C2239176 | |
| Disease | Hydrops Fetalis | 3.88e-03 | 19 | 145 | 2 | C0020305 | |
| Disease | Infiltrating duct carcinoma of female breast | 4.74e-03 | 21 | 145 | 2 | C3165106 | |
| Disease | osteoarthritis | 4.90e-03 | 222 | 145 | 5 | MONDO_0005178 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GQQPVSLQEAKLLLK | 151 | Q9H2F5 | |
| LQALILTPAGAKQKE | 551 | Q9UGJ0 | |
| QILLNLLEKIPGKNA | 2926 | Q9NR48 | |
| PDILLELGQFKKTQI | 331 | P06276 | |
| KPELLARLQKDGVNQ | 221 | O00472 | |
| GNKLQVLGKDLLLPQ | 221 | P02750 | |
| KEILALIPNQNALLK | 226 | Q7L2Z9 | |
| GLQNLKLLDELPIAK | 291 | Q9H672 | |
| RQLSLNINKLPGDKL | 516 | Q58F21 | |
| LKPQNLLINERGELK | 266 | Q07002 | |
| KLLLQNILKRTQPGS | 1321 | Q12774 | |
| KLSQIKEKLLPLQGQ | 1261 | Q7Z2Y8 | |
| LCLKINVKLGGINNI | 561 | Q9UL18 | |
| IKELVKQGGLNLSPL | 216 | Q9BQ75 | |
| IQNLKGLNSPVLIGK | 716 | Q4L235 | |
| LIKQSQKPLSLQGIC | 366 | A6NGH8 | |
| SLGEALKQLPKQNKL | 1476 | Q96M86 | |
| LKINVKLGGINNILV | 566 | Q9H9G7 | |
| ENGNLKEKDILVLPL | 96 | Q9Y394 | |
| LLPLRQKQQKSIQGE | 421 | Q5T5Y3 | |
| IQAAGKLVLIDKLLP | 1286 | Q9P2D1 | |
| LQVLKLLLNLAENPA | 261 | Q9UH62 | |
| LTLKQNEVLPGAKLD | 296 | Q96BY7 | |
| KINVKLGGVNNILLP | 566 | Q9UKV8 | |
| KTLQALQIPAAKLEG | 556 | P46940 | |
| LNPLNQDELKALKVI | 116 | Q9NUG6 | |
| NQQVKPLGLVLRKLL | 186 | Q9Y5H5 | |
| IIGNLFQLELKNIPK | 41 | P05181 | |
| QLSLAPGQLILILKK | 1071 | Q9NZM3 | |
| EQNILKQVFGILKAP | 511 | Q14573 | |
| GLQPLSAKKQLSIQI | 436 | Q9NPG4 | |
| NQQVKPLGLVLRKLL | 186 | Q9UN72 | |
| QGNTQVSRKKLLPLL | 341 | Q86TP1 | |
| NLVGQTLGKPLLIKE | 191 | Q5VVH5 | |
| DQPLAKDKVALLIGN | 336 | Q9UDY8 | |
| LKILMLQNNQLGGIP | 116 | Q9HBX8 | |
| IGNLKSELLLNILKQ | 3226 | Q03001 | |
| AIDINEPIGNLKKLL | 41 | Q06546 | |
| TPLKQLILLSLDKNQ | 201 | A6NM62 | |
| LQLKQLLQAKPFQPA | 1481 | O60318 | |
| IINSKFPQIGELILK | 221 | Q9HCG8 | |
| IAQLDPEALGNIKKL | 251 | Q53HL2 | |
| LTPQILVNNLKKGTI | 346 | O95786 | |
| AKLKSPQAVLQLGVN | 151 | Q9Y6G5 | |
| IVQKAPNLKILNLSG | 286 | Q9UBU9 | |
| PNLKILNLSGNELKS | 291 | Q9UBU9 | |
| GTQENKVKPLLLQLQ | 646 | Q14999 | |
| LQLKALKPGVIQILG | 81 | Q9NSA1 | |
| KLNTLLQRAPQCLGK | 551 | Q00839 | |
| VKEIGLLKQLNHPNI | 91 | Q9HC98 | |
| NGLPVELKQLKNIRA | 111 | Q8N456 | |
| QNELKPGSVLLLKQI | 536 | Q8N3J3 | |
| CLKNLQILKLRNNPI | 366 | Q05C16 | |
| NNKITTINGLNKLPI | 246 | Q96M69 | |
| TINGLNKLPIKILCL | 251 | Q96M69 | |
| KQLIQNNLFEIGIPK | 671 | Q5XXA6 | |
| PQNLLINEKGELKLA | 316 | Q00537 | |
| KKELNNEILGPVIQF | 66 | Q8N2Q7 | |
| GDLLKDLNLSLIPNK | 41 | Q9BZA7 | |
| VIGLQNLLVQKDPLL | 1106 | Q5TIA1 | |
| QIDISDKNGLLVLPK | 561 | Q9BX63 | |
| QPIQKVAKNLILFLG | 46 | P09923 | |
| EQLKKVILPQVLLGL | 371 | Q8IZE3 | |
| NKQKANLIVLGAVPR | 51 | Q8IUR7 | |
| LLPAACLLQLKGVKQ | 106 | Q53G59 | |
| QKVLVTVPLALLQKG | 621 | Q8NB78 | |
| LPPEKRKQANLAQLL | 26 | Q6ZUS6 | |
| KPQNLLISHLGELKL | 226 | Q96Q40 | |
| LQDQLLGIVAAKEKP | 3201 | Q8TD57 | |
| LKQLKHPNLVNLLEV | 56 | Q00532 | |
| GLLDLNNAILQLVKK | 341 | P62508 | |
| GKAKLLNQVLVNLPT | 46 | O15432 | |
| KQKIALLPNNAADLG | 216 | Q6UXH8 | |
| LVPNKKVGLQFLQRQ | 516 | Q02318 | |
| PKKGIQFLVENELLQ | 76 | Q99418 | |
| KKQLEILQLAQAQGL | 661 | Q5T0F9 | |
| PKKGIQFLIENDLLQ | 81 | O43739 | |
| LKPLKGVDPNLINNL | 56 | Q16739 | |
| ILNILNKLILDQLGG | 611 | Q99698 | |
| QLEKELLNGQKLQGP | 286 | P21695 | |
| QALKLIQILKGQSLL | 221 | Q17RS7 | |
| ILAKHLNDGKINQLP | 331 | Q5T6L9 | |
| LNVPDDILQLLKKNG | 301 | Q9H4B8 | |
| QEQLLKLGVPLTLDK | 1681 | A6NE01 | |
| LKNKGVQPLLDAVLE | 301 | Q96RP9 | |
| QALLNKAKLPLGLLL | 571 | O95487 | |
| GLAVLELQNKLPKAR | 456 | A3KN83 | |
| LVLILIVAPKKGQTN | 221 | Q6NVV3 | |
| KQLIVLGNKVDLLPQ | 241 | Q8NC60 | |
| KALLVQVVNKLGDPQ | 381 | Q03701 | |
| PASQQKPILNLALKL | 321 | Q5VW36 | |
| PLQKELQETLKGLLG | 491 | Q969Z0 | |
| QLALQKVPNLKFLDL | 256 | Q6UXK5 | |
| LKQLLQTQDKLTPAG | 691 | Q13029 | |
| LGNLKILKNEVNGKP | 1066 | P0DJD0 | |
| RQIPQLKKDIQDGLL | 526 | P42345 | |
| LALLLQAKLPSGKLQ | 356 | Q13505 | |
| PVIAKALQQLKNDAL | 981 | Q9Y6R4 | |
| LGNIIKSQLLKDPQV | 41 | Q9H1A7 | |
| LQQLNLQLPLKTKAF | 806 | P08581 | |
| SALKNKGIQPLLDAV | 331 | Q969S9 | |
| NAEILLKLINLGKLP | 411 | Q9GZN6 | |
| LPHLKTLILNGNKLE | 371 | Q9BXR5 | |
| NRLLQQKLSLDGNPK | 151 | Q9NUQ6 | |
| VREQQLKLPKPQLQL | 351 | Q6ZMQ8 | |
| KALLLEAQKGPVSLQ | 231 | Q96ER9 | |
| TQAKQKFLLLLPGLE | 956 | Q5UIP0 | |
| GPKLVKLLTGNQDLL | 391 | Q5K651 | |
| TQALLNKAKLPLGLL | 396 | O95486 | |
| DLQQLQKLKGLQPPV | 391 | Q587J7 | |
| LKQPESNLGIEIKAL | 216 | O14793 | |
| LNLLGILLKKDNLNQ | 711 | Q96Q15 | |
| KVLGELNILPNTQKV | 331 | Q8NEK8 | |
| QILVLQEGKLQKLAQ | 671 | Q03519 | |
| LPCVKKIIQQVLQGL | 186 | Q96SB4 | |
| LKKVRPLNNEGSLNL | 1486 | Q5VT25 | |
| LKNNVLQLPLCEKTI | 726 | Q9NRH2 | |
| NPQLKQIEGLVKELL | 566 | Q13438 | |
| LLNFLPEGVNKLKIS | 116 | Q5VWP2 | |
| LPILDNLLKANVINK | 476 | Q13490 | |
| NIGLTSIANLPKLNK | 51 | O95626 | |
| PQNLLIDDKGTIKLA | 131 | P06493 | |
| LNQPKAVLQKLAALS | 1256 | Q9HAW4 | |
| KEGLLGLQNLLKNQR | 671 | O75122 | |
| LQLGVQLLPKKLVVH | 131 | Q17RW2 | |
| LGNIIKSQLLKDPQV | 41 | Q9GZM3 | |
| LNKNKLQVLPELLFQ | 116 | O75094 | |
| NNLLPGLVVKAQVQK | 276 | Q14690 | |
| VGQQVTKPNLILKLE | 66 | P17025 | |
| QLISKGQPNPLKNIL | 41 | Q9H900 | |
| PDNQKLGLLEALLKI | 341 | Q8NI27 | |
| QFLDKILPDVNLGKI | 691 | Q9Y5W7 | |
| LPKLEVLDLAGNQLK | 676 | Q9NR96 | |
| LILGNILKIINNNLG | 3171 | Q15413 | |
| KPGLKNLNLIFIVLE | 11 | Q9BQ15 | |
| IKHLNILKLQGPISL | 816 | Q3MJ13 | |
| DQLAQQLQKALVGKP | 101 | Q6ZS81 | |
| LLNGLDPQKIKQLNL | 516 | P53804 | |
| NKNIPEILKIQIIGL | 546 | Q709C8 | |
| NKLPQRTAKLNLLLG | 306 | Q9Y5Z9 | |
| KQKQVEGLPELLDLN | 751 | Q9BQI6 | |
| PINLGLNVNDLLKQK | 206 | P50616 | |
| LLLNNELKKGPALFL | 366 | Q6PKC3 | |
| ALPNLGRLQKKLLQT | 81 | Q6ZTR6 | |
| LRILKIIPLNQGLKS | 211 | Q01118 | |
| SPKLLGELLQDNAKL | 256 | P37837 | |
| LINDILGELVKLGNK | 191 | Q9C0D7 | |
| NNLIPVDQLGQKLLK | 356 | Q9NVE5 | |
| PVQIQTQLLQKNLGK | 1126 | Q68DK2 | |
| VNQLRGILKLLQLLK | 391 | Q99959 | |
| GILKLLQLLKVQNED | 396 | Q99959 | |
| SVLLNIQEIKLKNPG | 111 | P35125 | |
| FVVELQGLLLPQDKK | 56 | Q9UNY4 | |
| LPDKGQKLIKQIQEL | 436 | Q9UNY4 | |
| TLGNIIKSQLLKDPQ | 41 | P52435 | |
| NQPRDIGLQIKALIK | 236 | P20592 | |
| VTNQIALLKLGKLPL | 296 | Q58DX5 |